Cardio Diagnostics Holdings Inc. Common stock Share Price
CDIOCardio Diagnostics Holdings Inc. Common stock Stock Performance
Open $1.20 | Prev. Close $1.11 | Circuit Range N/A |
Day Range $1.06 - $1.20 | Year Range $1.06 - $20.48 | Volume 747 |
Average Traded $1.14 |
Cardio Diagnostics Holdings Inc. Common stock Share Price Chart
About Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, including concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
Cardio Diagnostics Holdings Inc. Common stock Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
05-Feb-26 | $1.20 | $1.06 | +0.00% |
05-Feb-26 | $1.20 | $1.06 | -14.11% |
04-Feb-26 | $1.28 | $1.24 | -8.82% |
03-Feb-26 | $1.43 | $1.36 | -7.48% |
02-Feb-26 | $1.47 | $1.47 | -2.00% |
30-Jan-26 | $1.57 | $1.50 | -6.25% |
29-Jan-26 | $1.71 | $1.60 | -10.11% |